Substance / Medication

Aurothioglucose

Overview

Active Ingredient
aurothioglucose
RxNorm CUI
4980

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

3 trials linked to this intervention

3
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Targeting protein kinase C signaling cascades in alzheimer's disease: emerging neuroprotective roles of aurothioglucose.
Kushawaha Shiv Kumar, Vashisht Kanika, Kumar Himanshu et al. · Inflammopharmacology · 2025
PMID: 41331379Review
Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.
Kushawaha Shiv Kumar, Ashawat Mahendra Singh, Soni Divya et al. · Brain Res · 2024
PMID: 38570152Preclinical
Aurothioglucose enhances proangiogenic pathway activation in lungs from room air and hyperoxia-exposed newborn mice.
Dunigan-Russell Katelyn, Lin Vivian, Silverberg Mary et al. · Am J Physiol Lung Cell Mol Physiol · 2020
PMID: 32292070PreclinicalFull text (PMC)
Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.
Li Qian, Li Rui, Wall Stephanie B et al. · Am J Physiol Lung Cell Mol Physiol · 2018
PMID: 29368550PreclinicalFull text (PMC)
Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
van Roon Eric N, van de Laar Mart A F J, Janssen Matthijs et al. · J Rheumatol · 2005
PMID: 15940762Trial
Development of obesity and neurochemical backing in aurothioglucose-treated mice.
Kishi E, Takahashi A, Ishimaru H et al. · Auton Neurosci · 2001
PMID: 11570700Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Aurothioglucose (substance)
SNOMED CT
21880003
UMLS CUI
C0018033
RxNorm CUI
4980

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

4
Conditions
2
Biomarkers
1
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.